Douglas L. Huseby

3.3k total citations · 2 hit papers
30 papers, 2.2k citations indexed

About

Douglas L. Huseby is a scholar working on Molecular Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Douglas L. Huseby has authored 30 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Medicine, 14 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Douglas L. Huseby's work include Antibiotic Resistance in Bacteria (14 papers), Bacterial Genetics and Biotechnology (10 papers) and Bacteriophages and microbial interactions (7 papers). Douglas L. Huseby is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Bacterial Genetics and Biotechnology (10 papers) and Bacteriophages and microbial interactions (7 papers). Douglas L. Huseby collaborates with scholars based in Sweden, United States and United Kingdom. Douglas L. Huseby's co-authors include John R. Roth, Maria G. Winter, Parameth Thiennimitr, Renée M. Tsolis, Andreas J. Bäumler, Sebastian Winter, Diarmaid Hughes, Robert W. Crawford, L. Garry Adams and Brian P. Butler and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Douglas L. Huseby

29 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut inflammation provides a respiratory electron acceptor for Salmonella

2010 960 citations Sebastian Winter, Parameth Thiennimitr et al. Nature profile →
Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota

2011 497 citations Parameth Thiennimitr, Sebastian Winter et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas L. Huseby Sweden	17	1.2k	681	618	414	393	30	2.2k
Chloë E. James United Kingdom	25	1.0k 0.9×	319 0.5×	522 0.8×	538 1.3×	461 1.2×	34	2.7k
Emilia Ghelardi Italy	35	1.5k 1.3×	702 1.0×	585 0.9×	258 0.6×	342 0.9×	117	3.2k
Olivier Gaillot France	22	839 0.7×	353 0.5×	564 0.9×	386 0.9×	301 0.8×	45	2.3k
Ajay Kumar Goel India	25	708 0.6×	278 0.4×	346 0.6×	471 1.1×	166 0.4×	103	2.0k
Marcus B. Jones United States	32	1.8k 1.5×	589 0.9×	904 1.5×	354 0.9×	544 1.4×	56	3.3k
Christine J. Boinett United Kingdom	21	561 0.5×	169 0.2×	314 0.5×	266 0.6×	205 0.5×	39	1.4k
Julien Delmas France	31	1.7k 1.5×	343 0.5×	603 1.0×	707 1.7×	411 1.0×	57	3.0k
Elizabeth J. Klemm United Kingdom	17	432 0.4×	602 0.9×	338 0.5×	374 0.9×	97 0.2×	22	1.7k
Ruobing Wang China	28	732 0.6×	212 0.3×	369 0.6×	514 1.2×	127 0.3×	96	3.0k
Roxane Maria Fontes Piazza Brazil	19	347 0.3×	408 0.6×	695 1.1×	890 2.1×	188 0.5×	87	1.7k

Countries citing papers authored by Douglas L. Huseby

Since Specialization

Citations

This map shows the geographic impact of Douglas L. Huseby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas L. Huseby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas L. Huseby more than expected).

Fields of papers citing papers by Douglas L. Huseby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas L. Huseby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas L. Huseby. The network helps show where Douglas L. Huseby may publish in the future.

Co-authorship network of co-authors of Douglas L. Huseby

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas L. Huseby. A scholar is included among the top collaborators of Douglas L. Huseby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas L. Huseby. Douglas L. Huseby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Sha, Gerrit Brandis, Douglas L. Huseby, & Diarmaid Hughes. (2022). Positive Selection during Niche Adaptation Results in Large-Scale and Irreversible Rearrangement of Chromosomal Gene Order in Bacteria. Molecular Biology and Evolution. 39(4). 11 indexed citations

Huseby, Douglas L., et al.. (2022). Evolution of Bacterial Interspecies Hybrids with Enlarged Chromosomes. Genome Biology and Evolution. 14(10).

Huseby, Douglas L., et al.. (2021). Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections. Proceedings of the National Academy of Sciences. 118(10). 42 indexed citations

Huseby, Douglas L., et al.. (2021). Phenotypic and genetic barriers to establishment of horizontally transferred genes encoding ribosomal protection proteins. Journal of Antimicrobial Chemotherapy. 76(6). 1441–1447. 5 indexed citations

Huseby, Douglas L., et al.. (2020). Genetic Architecture and Fitness of Bacterial Interspecies Hybrids. Molecular Biology and Evolution. 38(4). 1472–1481. 10 indexed citations

Huseby, Douglas L., et al.. (2020). Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli. Journal of Antimicrobial Chemotherapy. 76(1). 77–83. 15 indexed citations

Brandis, Gerrit, et al.. (2020). Mutant RNA polymerase can reduce susceptibility to antibiotics via ppGpp-independent induction of a stringent-like response. Journal of Antimicrobial Chemotherapy. 76(3). 606–615. 8 indexed citations

Huseby, Douglas L., et al.. (2020). Antibiotic resistance by high-level intrinsic suppression of a frameshift mutation in an essential gene. Proceedings of the National Academy of Sciences. 117(6). 3185–3191. 20 indexed citations

Loža, Einārs, Mārtiņš Katkevičs, Victoria Ryabova, et al.. (2020). Structure-activity relationship studies on the inhibition of the bacterial translation of novel Odilorhabdins analogues. Bioorganic & Medicinal Chemistry. 28(11). 115469–115469. 5 indexed citations

10.

Juhas, Mario, Emma Widlake, Jeanette Teo, et al.. (2018). In vitroactivity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae andAcinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 74(4). 944–952. 78 indexed citations

11.

Cao, Sha, Douglas L. Huseby, Gerrit Brandis, & Diarmaid Hughes. (2017). Alternative Evolutionary Pathways for Drug-Resistant Small Colony Variant Mutants in Staphylococcus aureus. mBio. 8(3). 42 indexed citations

12.

Huseby, Douglas L., et al.. (2017). Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli. Journal of Antimicrobial Chemotherapy. 72(11). 3016–3024. 36 indexed citations

13.

Huseby, Douglas L., et al.. (2017). Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli. Molecular Biology and Evolution. 34(5). msx052–msx052. 71 indexed citations

14.

Qazi, Khaleda Rahman, Claudia Carvalho‐Queiroz, Omneya Ahmed Osman, et al.. (2017). Early-Life Human Microbiota Associated With Childhood Allergy Promotes the T Helper 17 Axis in Mice. Frontiers in Immunology. 8. 1699–1699. 12 indexed citations

15.

Pietsch, Franziska, Gerrit Brandis, Linda L. Marcusson, et al.. (2016). Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects. Journal of Antimicrobial Chemotherapy. 72(1). 75–84. 49 indexed citations

16.

Thiennimitr, Parameth, Sebastian Winter, Maria G. Winter, et al.. (2011). Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proceedings of the National Academy of Sciences. 108(42). 17480–17485. 497 indexed citations breakdown →

17.

Winter, Sebastian, Parameth Thiennimitr, Maria G. Winter, et al.. (2010). Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature. 467(7314). 426–429. 960 indexed citations breakdown →

18.

Huseby, Douglas L., et al.. (2005). Assembly of Human Immunodeficiency Virus Precursor Gag Proteins. Journal of Biological Chemistry. 280(18). 17664–17670. 46 indexed citations

19.

Huseby, Douglas L., et al.. (2002). Retrovirus Capsid Protein Assembly Arrangements. Journal of Molecular Biology. 325(1). 225–237. 60 indexed citations

20.

Vana, Marcy L., et al.. (2002). Analysis of rous sarcoma virus capsid protein variants assembled on lipid monolayers. Journal of Molecular Biology. 316(3). 667–678. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact